These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19492859)

  • 21. ConfGen: a conformational search method for efficient generation of bioactive conformers.
    Watts KS; Dalal P; Murphy RB; Sherman W; Friesner RA; Shelley JC
    J Chem Inf Model; 2010 Apr; 50(4):534-46. PubMed ID: 20373803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational analysis of single-base bulges in A-form DNA and RNA using a hierarchical approach and energetic evaluation with a continuum solvent model.
    Zacharias M; Sklenar H
    J Mol Biol; 1999 Jun; 289(2):261-75. PubMed ID: 10366504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EADock: docking of small molecules into protein active sites with a multiobjective evolutionary optimization.
    Grosdidier A; Zoete V; Michielin O
    Proteins; 2007 Jun; 67(4):1010-25. PubMed ID: 17380512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling side-chain conformation for homologous proteins using an energy-based rotamer search.
    Wilson C; Gregoret LM; Agard DA
    J Mol Biol; 1993 Feb; 229(4):996-1006. PubMed ID: 8445659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-ray structure of a monomeric cyclophilin A-cyclosporin A crystal complex at 2.1 A resolution.
    Mikol V; Kallen J; Pflügl G; Walkinshaw MD
    J Mol Biol; 1993 Dec; 234(4):1119-30. PubMed ID: 8263916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational analysis of endothelin-1: effects of solvation free energy.
    Hempel JC; Fine RM; Hassan M; Ghoul W; Guaragna A; Koerber SC; Li Z; Hagler AT
    Biopolymers; 1995 Sep; 36(3):283-301. PubMed ID: 7669916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational differences of an immunosuppressant peptolide in a single crystal and in a crystal complex with human cyclophilin A.
    Mikol V; Taylor P; Kallen J; Walkinshaw MD
    J Mol Biol; 1998 Oct; 283(2):451-61. PubMed ID: 9769217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The molecular replacement solution and X-ray refinement to 2.8 A of a decameric complex of human cyclophilin A with the immunosuppressive drug cyclosporin A.
    Pflügl GM; Kallen J; Jansonius JN; Walkinshaw MD
    J Mol Biol; 1994 Dec; 244(4):385-409. PubMed ID: 7990129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T; Elcock AH
    J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postprocessing of docked protein-ligand complexes using implicit solvation models.
    Lindström A; Edvinsson L; Johansson A; Andersson CD; Andersson IE; Raubacher F; Linusson A
    J Chem Inf Model; 2011 Feb; 51(2):267-82. PubMed ID: 21309544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flexible ligand docking: a multistep strategy approach.
    Wang J; Kollman PA; Kuntz ID
    Proteins; 1999 Jul; 36(1):1-19. PubMed ID: 10373002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of water molecules in the structure-based design of (5-hydroxynorvaline)-2-cyclosporin: synthesis, biological activity, and crystallographic analysis with cyclophilin A.
    Mikol V; Papageorgiou C; Borer X
    J Med Chem; 1995 Aug; 38(17):3361-7. PubMed ID: 7650689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sanglifehrin-cyclophilin interaction: degradation work, synthetic macrocyclic analogues, X-ray crystal structure, and binding data.
    Sedrani R; Kallen J; Martin Cabrejas LM; Papageorgiou CD; Senia F; Rohrbach S; Wagner D; Thai B; Jutzi Eme AM; France J; Oberer L; Rihs G; Zenke G; Wagner J
    J Am Chem Soc; 2003 Apr; 125(13):3849-59. PubMed ID: 12656618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
    Mahasenan KV; Li C
    J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational automatic search method for stable docking models of protein and ligand.
    Mizutani MY; Tomioka N; Itai A
    J Mol Biol; 1994 Oct; 243(2):310-26. PubMed ID: 7932757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid protein-ligand docking using soft modes from molecular dynamics simulations to account for protein deformability: binding of FK506 to FKBP.
    Zacharias M
    Proteins; 2004 Mar; 54(4):759-67. PubMed ID: 14997571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein promiscuity: drug resistance and native functions--HIV-1 case.
    Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
    J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The three-dimensional structure of a Plasmodium falciparum cyclophilin in complex with the potent anti-malarial cyclosporin A.
    Peterson MR; Hall DR; Berriman M; Nunes JA; Leonard GA; Fairlamb AH; Hunter WN
    J Mol Biol; 2000 Apr; 298(1):123-33. PubMed ID: 10756109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docking and scoring with alternative side-chain conformations.
    Hartmann C; Antes I; Lengauer T
    Proteins; 2009 Feb; 74(3):712-26. PubMed ID: 18704939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATTRACT: protein-protein docking in CAPRI using a reduced protein model.
    Zacharias M
    Proteins; 2005 Aug; 60(2):252-6. PubMed ID: 15981270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.